Trial Profile
A Multi-center, Randomized, Double-blind, Double-dummy Parallel-controlled Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jan 2018
Price :
$35
*
At a glance
- Drugs Nemonoxacin (Primary)
- Indications Community-acquired pneumonia
- Focus Pharmacokinetics; Therapeutic Use
- 01 Mar 2012 New trial record